Sequestration threatens faster FDA reviews, Hamburg says

03/18/2013 | Boston Herald

Across-the-board sequestration cuts could hurt the FDA's efforts to accelerate new drug reviews, said FDA Commissioner Dr. Margaret Hamburg during MassBio's annual meeting. Hamburg said she hopes Congress will allow the agency to put user fees paid by drugmakers toward its operating expenses.

View Full Article in:

Boston Herald

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Vice President
Health Alliance Plan of Michigan
Southfield, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA